SB 646

  • Rhode Island Senate Bill
  • 2021 Regular Session
  • Introduced in Senate Mar 18, 2021
  • Passed Senate Jun 08, 2021
  • House
  • Governor

AN ACT RELATING TO INSURANCE (Requires coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobin therapy.)

Votes


No votes to display

Actions


Jun 29, 2021

Rhode Island General Assembly

06/29/2021 Committee recommends passage of Sub A in concurrence

Jun 27, 2021

Rhode Island General Assembly

06/27/2021 Scheduled for consideration (06/29/2021)

Jun 10, 2021

House

06/10/2021 Referred to House Health & Human Services

Jun 08, 2021

Senate

06/08/2021 Senate passed Sub A

Jun 04, 2021

Senate

06/04/2021 Placed on Senate Calendar (06/08/2021)

Jun 03, 2021

Rhode Island General Assembly

06/03/2021 Committee recommends passage of Sub A

Jun 02, 2021

Rhode Island General Assembly

06/02/2021 Proposed Substitute

May 28, 2021

Rhode Island General Assembly

05/28/2021 Scheduled for consideration (06/03/2021)

Apr 29, 2021

Rhode Island General Assembly

04/29/2021 Committee recommended measure be held for further study

Apr 23, 2021

Rhode Island General Assembly

04/23/2021 Scheduled for hearing and/or consideration (04/29/2021)

Mar 18, 2021

Senate

03/18/2021 Introduced, referred to Senate Health and Human Services

Bill Text

Bill Text Versions Format
646  SUB A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Rhode Island General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.